# Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas

> **NCT01140360** · PHASE1,PHASE2 · COMPLETED · sponsor: **Kent Robertson** · enrollment: 21 (actual)

## Conditions studied

- Neurofibromatosis
- Neurofibromas

## Interventions

- **DRUG:** Gleevec

## Key facts

- **NCT ID:** NCT01140360
- **Lead sponsor:** Kent Robertson
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2016-08
- **Final completion:** 2016-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01140360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01140360, "Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01140360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*